New drug duo aims to wipe out esophageal cancer before surgery
Disease control
Recruiting now
This study tests whether adding the drug adebrelimab to standard chemotherapy before surgery can completely eliminate esophageal cancer in 25 patients with locally advanced disease. The main goal is to see how many patients have no cancer left after treatment. Researchers will al…
Phase: NA • Sponsor: The Second Hospital of Shandong University • Aim: Disease control
Last updated May 01, 2026 15:57 UTC